Kieran Ryan
Stock Analyst at Deutsche Bank
(2.19)
# 3,203
Out of 4,676 analysts
5
Total ratings
100%
Success rate
11.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kieran Ryan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintained: Buy | $190 → $180 | $143.05 | +25.83% | 2 | Aug 6, 2026 | |
| DXCM DexCom | Rated: Buy | $86 → $92 | $89.16 | +3.19% | 2 | Jul 31, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | $16 | $21.58 | -28.17% | 1 | Jun 23, 2026 |
Insulet
Aug 6, 2026
Maintained: Buy
Price Target: $190 → $180
Current: $143.05
Upside: +25.83%
DexCom
Jul 31, 2026
Rated: Buy
Price Target: $86 → $92
Current: $89.16
Upside: +3.19%
Tandem Diabetes Care
Jun 23, 2026
Initiated Coverage: Hold
Price Target: $16
Current: $21.58
Upside: -28.17%